Case Studies
NCS Analytics Partners with Cannabiz Credit Association on Lending Data
DENVER – NCS Analytics and Cannabiz Credit Association have entered ...
Metrc Rolls Out Compliance Events for New York Cannabis Operators
NEW YORK – Track-and-trace provider Metrc announced a pair of ...
Eli Lilly Completes Acquisition of AtaiBeckley
INDIANAPOLIS – Eli Lilly & Co. has closed its acquisition ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
RYTHM Reports Q2 2026 Financial Results
ROLLING MEADOWS – RHYTHM, Inc. posted revenue from continuing operations of $23 million in the second quarter of 2026, a 73% sequential increase that cleared management's own guidance of 65% growth. For context. Total revenue ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The final days of July and the opening of August delivered a concentrated burst of news that touched labor, capital markets, federal regulation, and cross-border insolvency. A historic labor settlement, a one-company ...
MJBowl Adds Colorado for Its Second Year
LOS ANGELES – The MJBowl, the Cannabis product competition co-presented by MJBizCon and professional review platform Budist, is returning for its second year, with Colorado joining California and New York in the competition pool for ...
FDA Issues Final Guidance on Psychedelic Drug Trials
SILVER SPRING – The FDA published its final guidance titled "Psychedelic Drugs: Considerations for Clinical Investigations" in the Federal Register, finalizing a draft that first appeared in June 2023. Issued by the Center for Drug ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...
Analysis: Wall Street Quietly Tests the Water In Cannabis
NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...
BREAKING: Trump Signals Possible Cannabis Reclassification Within Weeks
LOS ANGELES- President Donald Trump said Monday that his administration is actively considering shifting Cannabis to a lower-risk category under federal law — a move that could have sweeping implications for the industry. Speaking at ...
Snoop Dogg’s Death Row Cannabis Enters Ohio Market
COLUMBUS – Death Row Records Cannabis, the Cannabis brand launched by rapper and entrepreneur Calvin Cordozar Broadus Jr., commonly known as Snoop Dogg, has expanded into Ohio through a partnership with Pure Ohio Wellness. This ...
Trump Considers Shift in Federal Cannabis Rescheduling
LOS ANGELES – President Donald Trump is exploring a move to reclassify Cannabis from Schedule I to Schedule III under federal law, according to a report from The Wall Street Journal. The potential policy shift, ...
Village Farms International Reports Q2 2025 Financial Results
VANCOUVER – Village Farms International, Inc. reported its financial results for the second quarter of 2025, indicating record profitability and performance of strategic shifts, including the privatization of parts of its produce segment, which has ...
Canopy Growth Corp Reports Q1 FY2026 Financial Results
SMITHS FALLS – Canopy Growth Corp. released its financial results for the first quarter of fiscal year 2026, ending June 30, 2025, showcasing a 9% increase in net revenue to $72.1 million compared to $66.2 ...
Case Study: Grupo Flor: A Cannabis Turnaround Driven by Strategic Focus
SALINAS- When Mark Collins joined Grupo Flor as Chief Financial Officer, the California-based vertically integrated Cannabis company was in severe financial and operational distress. The business held multiple licenses across retail, cultivation, manufacturing, and distribution—far ...
Cannabis Stocks Rally as U.S. Rescheduling Debate Heats Up
LOS ANGELES — For the first time in more than a year, cannabis stocks are enjoying a sustained rally. Exchange-traded funds focused on the sector have climbed sharply in recent weeks, and several of the ...
Did Psilocybin Arrive From Outer Space? New Genomic Study Opens the Door to a Cosmic Possibility
LOS ANGELES — The psychedelic compound psilocybin has long intrigued researchers for its potential to treat mental health conditions, but a groundbreaking study is now shedding new light on where these mushrooms came from—and it’s ...
Will Hope Fuel Cannabis Industry Growth Beyond Q2 2025?
LOS ANGELES – If you’ve been scrolling through the latest updates on the Highly Capitalized Network’s website or LinkedIn, you’ve likely caught the wave of Q2 2025 earnings reports sparking cautious optimism across the Cannabis ...
TerrAscend Reports Q2 2025 Financial Results
TORONTO – TerrAscend Corp. released its financial results for the second quarter of 2025, highlighting stable performance and strategic shifts. The company reported net revenue of $65 million, a slight decline from $67.2 million in ...
Ascend Wellness Holdings Reports Q2 2025 Financial Results
NEW YORK – Ascend Wellness Holdings, Inc., a multi-state Cannabis operator, shared its financial performance for the second quarter of 2025, confirming steady performance, a fortified balance sheet, and ongoing retail growth. The company recorded ...
Cronos Group Inc Reports Q2 2025 Financial Results
TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...
Cresco Labs Reports Q2 2025 Financial Results
CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...
The Cannabist Co Holdings Reports Q2 2025 Financial and Operational Results
CHELMSFORD – The Cannabist Company Holdings Inc., a leading U.S. Cannabis cultivator, manufacturer, and retailer, released its financial and operational results for the second quarter of 2025, indicating ongoing efforts to streamline operations and strengthen ...
MariMed Reports Q2 2025 Financial Results
NORWOOD – MariMed Inc. released its financial results for Q2 2025 ended June 30, reflecting a blend of operational growth and financial challenges. The company reported revenue of $39.6 million, a slight decline from $40.4 ...
Will the Hemp Beverage Category Still Be Here in 12 Months?
LOS ANGELES- Will the Hemp Beverage Category Still Be Here in 12 Months? That's not just a provocative question—it’s a quiet but growing concern across the hemp industry. After a explosive rise in popularity, hemp-derived THC ...
Verano Holdings Corp Reports Q2 2025 Financial Results
CHICAGO – Verano Holdings Corp., a multi-state Cannabis operator, released its financial results for the second quarter of 2025, reflecting a period of operational streamlining amid market challenges. The consolidated financial statements, prepared under U.S. ...
Curaleaf Reports Q2 2025 Financial Results
STAMFORD – Curaleaf Holdings, Inc., a major player in the global Cannabis market, released its financial and operational results for the second quarter of 2025, ending June 30, showcasing a blend of domestic resilience and ...
GTI Reports Q2 2025 Financial and Operational Results
CHICAGO & VANCOUVER – Green Thumb Industries Inc., a major player in the U.S. Cannabis market, national Cannabis consumer packaged goods (CPG) company, and operator of RISE Dispensaries, reported its financial and operational results for ...
Trulieve Cannabis Corp Reports Q2 2025 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp., a major player in the U.S. Cannabis market, announced its financial and operational results for the second quarter of 2025, ending June 30, showcasing resilience and strategic progress. The company ...
Aurora Cannabis Reports Q1 FY2026 Financial Results
EDMONTON – Aurora Cannabis Inc. (ACB), a leading Canadian Cannabis producer, announced its financial and operational results for the first quarter of fiscal 2026, ending June 30, 2025, showcasing robust growth in its medical Cannabis ...
AYR Wellness Exits Massachusetts in Broad Financial Restructuring
LOS ANGELES – AYR Wellness, a Miami-based multi-state Cannabis operator, is pulling out of Massachusetts as part of a bold restructuring to tackle its financial challenges. The company will close its 90,000-square-foot Milford cultivation facility, ...
Canopy Growth Expands its Presence in Australia
OTTAWA – Canopy Growth Corporation has introduced its Canadian-grown 7ACRES brand to the Australian medical Cannabis market, marking a strategic expansion of its global medical portfolio. The launch, announced on August 5, features two high-THC ...
Jushi Holdings Reports Q2 2025 Financial Results
LOS ANGELES – Jushi Holdings Inc. reported its Q2 2025 financial results, reflecting modest revenue growth and operational advances as it expands its retail footprint and refines its cultivation strategy. The company posted revenue of ...
Senate Pushes for Cannabis and Psychedelics Research Amid Schedule I Restrictions
WASHIGTON D.C. – The Senate Appropriations Committee approved a substantial spending bill addressing Labor, Health and Human Services, Education, and Related Agencies (LaborHHS), including provisions that could reshape the scope of research into Schedule I ...
